Autonomix Medical, Inc. Cash Flow Statement
AMIX|3 years of annual SEC 10-K data (FY2024-FY2026)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 3 fiscal years. All figures from audited SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -5.47 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Net Income | - | -$16.7M | -$2.0M |
| Depreciation & Amortization | - | $12.0K | $0 |
| Operating Cash Flow | - | -$12.3M | -$1.9M |
| Capital Expenditures | - | $10.0K | $0 |
| Free Cash Flow | - | -$12.3M | -$1.9M |